Blue Bell Private Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Blue Bell Private Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-318	Closed	-$37K	–	713
2022 Q3	$37K	Sell	318 -50	-14%	-$6.21K	0.01%	236
2022 Q2	$43K	Sell	368 -450	-55%	-$53.4K	0.01%	229
2022 Q1	$107K	Buy	818 +80	+11%	+$10.4K	0.03%	161
2021 Q4	$113K	Buy	+738	New	+$114K	0.03%	154

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CANY

Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Blue Bell Private Wealth Management's IBB Position: Q4 2022 in Review

Blue Bell Private Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q4 2022, closing a stake of 318 shares — an estimated $37K sold.

Blue Bell Private Wealth Management first reported a position in IBB in Q4 2021 and held it in 4 quarters. The position peaked at $113K in Q4 2021. 902 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

Blue Bell Private Wealth Management reported no remaining iShares Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
Blue Bell Private Wealth Management sold 318 iShares Biotechnology ETF shares in Q4 2022, an estimated $37K.
Blue Bell Private Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 4 quarters.
Blue Bell Private Wealth Management's iShares Biotechnology ETF position peaked at $113K in Q4 2021.
902 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on Blue Bell Private Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.